Introducing Anoro Ellipta
Anoro Ellipta (55 micrograms/22 micrograms inhalation powder) is a long acting muscarinic agonist/long acting Beta2-adrenergic agonists (LAMA/LABA) and is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).1
Anoro Ellipta Head-to-Head Study
Watch lead author Dr. Gregory Feldman provide an overview of the Anoro Ellipta Head-to-Head Study by clicking the video above
- Anoro Ellipta 52/22 mcg SPC.
- Feldman G.J et al. Adv Ther 2017; 34:doi 10.1007/s12325-017-0626-4.